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O B J E C T I V E S In thepresent study,we investigated the associationof pathologicalQwaveswith infarct size.
Furthermore, we investigated whether Q-wave regression was associated with improvement of left ventricular
ejection fraction (LVEF), infarct size, and left ventricular dimensions in ST-segment elevation myocardial infarction
(STEMI) patients with early Q-wave formation compared with patients without or persistent pathological Q waves.
B A C KG ROUND The criteria for pathological Q waves after acute myocardial infarction (MI) have changed
over the years. Also, there are limited data regarding correlation of Q-wave regression and preservation of LVEF in
patients with an initial Q-wave MI.
METHOD S Standard 12-lead electrocardiograms (ECGs) were recorded in 184 STEMI patients treated with
primary percutaneous coronary intervention (PCI). ECGs were recorded before and following PCI, as well as at 1,
4, 12, and 24 months of follow-up. An ECG was scored as Q-wave MI when it showed Q waves in 2 or more
contiguous leads according to the 4 readily available clinical deﬁnitions used over the years: “classic” criteria,
Thrombolysis In Myocardial Infarction criteria, and 2000 and 2007 consensus criteria. Cardiac magnetic resonance
(CMR) examination was performed at 4  2 days after reperfusion and repeated after 4 and 24 months.
Contrast-enhanced CMR was performed at baseline and 4 months.
R E S U L T S The classic ECG criteria showed strongest correlation with infarct size as measured by CMR. The
incidence of Q-wave MI according to the classic criteria was 23% 1 h after PCI. At 24 months of follow-up, 40% of
patients with initial Q-wave MI displayed Q-wave regression. Patients with a Q-wave MI had larger infarct size and
lower LVEF on baseline CMR (24  10% LV mass and 37  8%, respectively) compared with patients with
non–Q-wave MI (17  9% LV mass, p  0.01, and 45  8%, p  0.001, respectively). Patients with Q-wave
regression displayed signiﬁcantly larger LVEF improvement in 24 months (9  11%) as compared with both
persistent Q-wave MI (2  8%) as well as non–Q-wave MI (3  8%, p  0.04 for both comparisons).
CONC L U S I O N S Association of Q waves with infarct size is strongest when using the classic Q-wave
criteria. Q-wave regression is associated with the largest improvement of LVEF as assessed with CMR. (J Am Coll
Cardiol Img 2013;6:324–31) © 2013 by the American College of Cardiology Foundation
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325T
he electrocardiogram (ECG) plays a pivotal
role in the diagnosis of myocardial infarction
(MI), due to low costs and universal availabil-
ity. On the basis of the ECG, patients pre-
enting with an acute coronary syndrome are strat-
fied in the acute setting into ST-segment elevation
yocardial infarction (STEMI) or non–ST-
egment elevation myocardial infarction. After the
cute setting, the ECG may show pathological Q
See page 332
waves. Pathological Q waves are considered the
classic ECG sign of necrosis and represent the area
of myocardium that cannot be depolarized. The
emergence of Q waves on the ECG constitutes
important prognostic value for clinicians. Several
post-mortem (1) and cardiac magnetic resonance
(CMR) studies (2–4) showed that Q-wave MIs are
larger.
A variety of definitions for pathological Q waves
have been published over the years. Earlier studies
defined the pathological Q-wave as being more
than 0.04 s of duration and with an amplitude of
more than 25% of the corresponding R-wave (5–7),
a criterion used since 1934. In 1999, the TIMI
(Thrombolysis In Myocardial Infarction) investiga-
tors classified Q waves as being pathological if they
lasted for more than 0.03 s based on the Selvester
criteria (8). Two consensus documents in 2000 (9)
and 2007 (10) redefined the ECG criteria yet again
(Table 1).
Moreover, it has been shown that in the era of
thrombolytic therapy, Q waves can disappear par-
tially or completely during the evolution of myocar-
dial infarction (11–13). This was observed in ap-
proximately 15% of the patients with a STEMI. It
is not clear though whether such Q-wave regression
can be used as a clinical tool because it is related to
shrinkage in infarct size or improvement of left
ventricular ejection fraction (LVEF).
We hypothesize that the classic, more strict,
criteria of Q-wave MI correlate best with infarct
size. Moreover, we hypothesize that Q-wave regres-
sion is related to shrinkage in infarct size and
improvement of LVEF. Therefore, in the present
study, we investigated the association of patholog-
ical Q waves with infarct size, focusing on readily
available clinical definitions of pathological Q-wave
formation. Furthermore, we investigated whether
Q-wave regression was associated with improve-
ment of LVEF, infarct size, and left ventricular
dimensions in STEMI patients with early Q-waveformation compared with patients without or per-
sistent pathological Q waves.
M E T H O D S
Patient population. The study population consisted
f 200 STEMI patients treated by primary percu-
aneous coronary intervention (PCI) undergoing
MR for research indications in 7 Dutch primary
CI centers. Patients with a history of myocardial
nfarction were excluded. All patients had under-
one primary PCI with stent implantation within
2 h of symptom onset. Patients were treated with
spirin, heparin, and a P2Y12 inhibitor according
o American College of Cardiology/American
eart Association practice guidelines.
Electrocardiography analysis. Standard 12-lead elec-
trocardiogram was recorded before and 1 h after the
procedure and at 1, 4, 12, and 24 months
of follow-up at a paper speed of 25 mm/s
and a sensitivity of 10 mm/mV. Pre- and
post-procedural ECGs were obtained at
the catheterization laboratory. At 4 and 24
months, an ECG was recorded on the
same day as CMR.
The ECG measurements were per-
formed in a blinded fashion without
knowledge of the results of the CMR or
earlier ECGs. In case of disagreement
regarding the ECG interpretation, a
consensus was reached by reading the
tracing together. All measurements were dig-
itally performed using ImageJ (Version
1.43u, National Institutes of Health 2010,
Bethesda, Maryland), enabling up to 0.01
ms accuracy. Measurements included
Q-wave depth and duration as well as R-wave
amplitude. All 12 leads except for AvR were used in
this analysis.
All ECGs were scored according to the 4 clini-
cally available definitions of Q-wave MI (5,6,8–10)
(see also Table 1). These data were used to deter-
mine which of the 4 definitions shows strongest
correlation with infarct size.
Q-wave regression was defined as re-classification
from initial Q-wave MI defined 1 h after PCI to
permanent non–Q-wave MI at 24 months of
follow-up. We excluded ECGs with QRS con-
founders, that is, left bundle branch block, left
ventricular hypertrophy, Wolff-Parkinson-White
syndrome. Patients with more than 2 missing
ECGs or ECGs of poor quality (n  9) were
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326Cardiac magnetic resonance. CMR examination was
erformed at 4  2 days after reperfusion and
epeated after 4 and 24 months. Contrast-enhanced
MR was performed at baseline and 4 months.
atients were studied on a clinical 1.5-T scanner.
ontiguous short-axis slices were acquired every 10
m, covering the whole LV from base to apex
sing a segmented steady-state free precession pulse
equence. Late gadolinium enhancement images
ere obtained 10 to 15 min after administration of
gadolinium-based contrast agent (Dotarem,
uerbet, Villepinte, France) (0.2 mmol/kg) using a
-dimensional segmented inversion recovery gradi-
nt echo pulse sequence, with slice position identi-
al to the cine images, to examine infarct size and
egmental transmural extent of infarction. Typical
n-plane resolution was 1.4  1.7 mm2, with slice
hickness 5.0 to 6.0 mm (repetition time/echo
ime  9.6/4.4 ms, flip angle 25°, triggering to
very other heartbeat). The CMR data were ana-
yzed using a dedicated software package (Mass
008beta, Medis, Leiden, the Netherlands). CMR
tudies were analyzed blinded to ECG results and
atient identity. On short-axis cine slices, the en-
ocardial and epicardial borders were outlined man-
ally on end-diastolic and end-systolic images.
rom these, LVEF was calculated. Infarct size was
etermined on the late gadolinium enhancement
mages as previously described using a standardized
nd pre-defined definition of hyperenhancement.
Table 1. Multiple Deﬁnitions of Pathological Q Waves
“Classic” criteria Q-wave with a duration 40 ms and/or
a depth 25% of the R-wave in the
same lead or the presence of a Q-
wave equivalent
TIMI criteria Q-wave 30 ms in 2 contiguous leads,
any Q- or R-wave 10 ms and 0.1
mV in lead V2, and R-wave 40 ms
in V1
Consensus 2000 Any Q-wave in leads V1 through V3,
Q-wave 30 ms in leads I, II aVL,
aVF, V4, V5, V6
The Q-wave changes must be present
in any 2 contiguous leads, and be
1 mm in depth
Consensus 2007 Any Q-wave in leads V2–V3 20 ms or
QS complex in leads V2 and V3
Q-wave 30 ms and 0.1 mV deep or
QS complex in leads I, II, aVL, aVF or
V4–V6 in any 2 leads of a contiguous
lead grouping (I, aVL, V6; V4–V6; II, III,
and aVF)
R-wave 40 ms in V1–V2 and R/S 1
with a concordant positive T-wave in
the absence of a conduction defect
TIMI  Thrombolysis In Myocardial Infarction.otal infarct size was expressed as percentage of LV bass (14). Transmural extent of infarction was
alculated by dividing the hyperenhanced area by
he total area of the pre-defined segment (%).
icrovascular obstruction (MVO) was assessed us-
ng late gadolinium enhancement and defined as
ny region of hypoenhancement within the hyper-
nhanced infarcted area. This area was included in
he calculation of total MI size. For analysis of
egional myocardial function, each short-axis slice was
ivided into 12 equiangular segments to calculate wall
hickening (in millimeters) of each segment by sub-
racting end-diastolic from end-systolic wall thickness.
yocardial segments were considered dysfunctional if
egmental wall thickening was 3 mm (15).
Statistical analysis. Values are reported as mean 
D or median (25th to 75th percentile) for contin-
ous variables and as frequency with percentages for
ategorical variables. Unpaired Student t test and a
isher exact test were used to compare differences
etween groups of continuous and categorical vari-
bles, respectively. Receiver-operating characteristic
ROC) curves were constructed to assess association
f Q-wave MI distinction based on the 4 different
riteria with infarct size. The comparison of areas
nder the ROC curves (AUC) was performed as
escribed by DeLong et al. (16). Also, the differ-
nces of infarct size between Q-wave and non–Q-
ave MI patients were assessed with the unpaired
tudent t test. Association of LVEF, LV dimen-
ions, and infarct size in patients with Q-wave
egression was compared with that of patients
ithout pathological Q waves and patients with
ersistent Q waves. For this analysis, Q waves were
lassified according to the criteria that had the best
ssociation with infarct size. No adjustments for
ultiple comparisons were made. All statistical
ests were 2-tailed, and a value of p  0.05 was
onsidered statistically significant. Calculations
ere generated by SPSS software (version 18.0 for
indows, SPSS, Chicago, Illinois).
R E S U L T S
During follow-up, 2 patients died due to noncardiac
causes, and 5 patients presented with myocardial
re-infarction. These patients were excluded from
the final study population. Table 2 shows the
clinical characteristics of the final study population.
Predictive value of different ECG criteria. In Figure 1,
OC curves for the 4 different Q-wave criteria are
hown for 1-h ECGs and the relation with infarct
ize. Association with infarct size was significantly
etter for Q-wave distinction based on the classic
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327criteria (23% classified as Q-wave MI; AUC: 0.71,
95% confidence interval [CI]: 0.60 to 0.82) com-
pared with the 2007 criteria (58% classified as
Q-wave MI; AUC: 0.57, 95% CI: 0.47 to 0.67, p
0.01) and 2000 and TIMI criteria (respectively,
55% classified as Q-wave MI; AUC: 0.57, 95% CI:
0.47 to 0.68, p  0.01, and 53% classified as
Q-wave MI; AUC: 0.57, 95% CI: 0.47 to 0.68, p
0.01). Similar results were shown for infarct size at
4 months; AUC of the classic criteria was 0.69 (95%
CI: 0.58 to 0.79) compared with the 2007 criteria
(0.58, 95% CI: 0.48 to 0.68, p  0.13) and 2000
nd TIMI criteria (respectively, AUC: 0.59, 95%
I: 0.49 to 0.69, p  0.14, and AUC: 0.60, 95%
I: 0.50 to 0.60, p  0.14).
Difference in infarct size (% of LV mass) between
atients with Q-wave and non–Q-wave MI accord-
ng to the 4 different criteria are described in Table 3.
e observed similar patterns for all other ECG time
oints as well as for infarct size at 4 months, also after
orrecting for infarct locations (data not shown).
Infarct size and LVEF in patients with Q-wave versus
non–Q-wave MI. Patients with Q-wave MI accord-
ing to the classic criteria had larger infarct size and
lower LVEF on baseline CMR (respectively, 24 
10% LV mass and 37  8%) compared with
patients with non–Q-wave MI (17  9% LV mass,
p  0.01, and 45  8%, p  0.001). Also at 4
months, this difference between patients with
Q-wave and non–Q-wave MIs was observed, and
Table 2. Clinical Characteristics of the Study Population
(N  184)
Demographics
Age, yrs 56 9
Male 156 (85)
Risk factors
Diabetes mellitus 12 (7)
Known hypertension 55 (30)
Family history of coronary heart disease 90 (49)
Hypercholesterolemia 35 (19)
Current cigarette smoking 93 (51)
Angiography and infarct treatment
Time from symptom onset to PCI, h 3.3 (2.2–4.6)
Infarct-related artery
Left anterior descending artery 118 (64)
Right coronary artery 43 (23)
Left circumﬂex artery 23 (13)
Multivessel disease 46 (25)
Values are mean  SD, n (%), or median (25th–75th percentile).
PCI  percutaneous coronary intervention.for LVEF also at 24 months (Table 4).Largest improvement of LVEF in patients with Q-wave
regression at 24 months. In patients with initial
Q-wave MI, Q-wave regression (both assessed
according to classic criteria) within 24 months of
follow-up was present in 40% of the patients (n 
17). Ten patients had Q-wave regression between
1 h and 1 month post-PCI. Seven patients had
Q-wave regression between 1 month and 4 months.
At baseline, patients with Q-wave regression and
patients with persistent Q-wave MI had compara-
ble LVEF and infarct size. However, at 4 months,
the Q-wave regression was accompanied by a de-
crease in infarct size and, at 24 months, with the
greatest improvement of LVEF over time, com-
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Figure 1. ROC Curves Describing the Association With Infarct Si
4 Different Criteria for Q-Wave/Non–Q-Wave MI Based on ECG 1 h
Receiver-operating characteristic (ROC) curves for the 4 different Q-
shown for 1-h ECGs and the relation with infarct size. Association w
signiﬁcantly better for Q-wave distinction based on the classic crite
under the curve; CI  conﬁdence interval; MI  myocardial infarcti
ous coronary intervention; TIMI  Thrombolysis In Myocardial Infar
Table 3. Infarct Size (% of LV Mass) for Q-Wave MI and
Non–Q-Wave MI as Assessed 1 h After PCI Comparing the 4
Widely Available Deﬁnitions
Non–Q-Wave MI Q-Wave MI p Value
“Classic” criteria 17 9 24 10 0.001
2000 criteria 18 10 20 10 0.28
TIMI criteria 18 10 21 10 0.16
2007 criteria 18 10 20 10 0.40
LV  left ventricular; MI  myocardial infarction; other abbreviations as inC 95% CI
71 0.60-0.82
57 0.47-0.68
57 0.47-0.68
57 0.47-0.67
.8 1.0
ze for the
After PCI
wave criteria are
ith infarct size was
ria. AUC  area
on; PCI  percutane-Tables 1 and 2.
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328pared with both persistent Q-wave MI as well as
non–Q-wave MI (Table 4 and Fig. 2). Infarcts in
the Q-wave regression group were not only larger
than in the non–Q-wave MI patients but also more
transmural. Size and extent of the infarcts at base-
line of Q-wave regression patients was comparable
to persistent Q-wave MI. However, MVO as as-
sessed on baseline CMR was more frequently pres-
ent in persistent Q-wave MI patients than in
patients displaying Q-wave regression (92% vs.
53%, p  0.002). At 4 months, there were no
patients with MVO.
Regional function and recovery. In Figure 3, the
regional wall thickness and function in dysfunc-
tional segments are shown. Although wall thicken-
ing of the dysfunctional segments at baseline was
similar between persistent Q-wave MI and Q-wave
regression patients (respectively, 1.0 mm and 0.9
mm, p 0.64), the improvement in wall thickening
was larger in patients with Q-wave regression (2.8
mm compared with 2.0 mm for persistent Q-wave,
p  0.03, see Fig. 3A). This is in line with the
differences in recovery of global LVEF between the
groups. There was a decrease in end-diastolic wall
thickness from baseline to 24 months follow-up in
all 3 groups. However, this decrease was larger in
the persistent Q-wave MI patients, (2.7 mm
compared with 1.9 mm for Q-wave regression
eristics of the Study Population Split for Non–Q-Wave, Q-Wave M
Non–Q-Wave MI
Persistent
Q-Wave MI
Q-W
Regre
184) (n  141) (n  26) (n 
ass
17 9 25 5 24
11 7 17 5 15
45 8 37 8 38
49 9 40 7 43
49 8 40 8 48
e, ml/m2
96 16 103 15 100
101 17 115 25 109
102 20 127 32 106
, ml/m2
53 15 66 14 60
52 16 70 21 65
54 19 78 27 59
ular obstruction 71 (53) 24 (92) 9 (5
ansmurality, % 11 12 22 13 19
n (%).
resonance; other abbreviations as in Table 3.and 1.6 mm for non–Q-wave MI, p  0.002 and 0.08, respectively (Fig. 3B). With regard to
egional systolic function, no change from 24
onths follow-up to baseline in end-systolic wall
hickness in the Q-wave regression and non–Q-
ave MI group was observed (0.1 mm compared
ith 0.2 mm, p  0.73). This was in contrast to a
ignificant decrease in end-systolic wall thickness in
he persistent Q-wave MI group (Fig. 3C) (1.7
m, p  0.001 and p  0.008, respectively). This
esulted in the described changes in wall thickening
uring follow-up (Fig. 3D).
D I S C U S S I O N
Association of infarct size on CMR was best when
making Q-wave/non–Q-wave distinction based on
the classic Q-wave criteria The Q-wave/non–Q-
wave MI distinction is of clinical relevance, because
Q waves are associated with a lower ejection frac-
tion and a larger MI. Q-wave regression at 24
months was present in 40% of the patients with
initial Q-wave MI and was associated with the
largest reduction of infarct size and improvement of
LVEF as assessed on CMR. Moreover, patients
with persistent Q waves had more often (92%)
MVO on baseline CMR.
Q-wave and incidence. We assessed Q-wave inci-
dence in a STEMI population treated with primary
nd Q-Wave Regression Groups According to the Classic Criteria
n
Non–Q-Wave MI
vs. Q-Wave MI
Non–Q-Wave MI
vs. Q-Wave
Regression
Q-Wave MI
vs. Q-Wave
Regression
p Value p Value p Value
0.02 0.36 0.58
0.02 0.03 0.86
0.001 0.02 0.72
0.001 0.002 0.23
0.001 0.55 0.02
0.045 0.44 0.39
0.01 0.20 0.56
0.001 0.50 0.10
0.001 0.28 0.46
0.001 0.03 0.46
0.001 0.29 0.12
0.001 1.00 0.002
0.001 0.03 0.47Table 4. CMR Charact I, a
CMR
ave
ssio
Total (N  17)
Infarct size, % of LV m
Baseline 14
4 months 7
LV ejection fraction, %
Baseline 7
4 months 10
24 months 11
LV end-diastolic volum
Baseline 12
4 months 30
24 months 42
LV end-systolic volume
Baseline 13
4 months 29
24 months† 38
Presence of microvasc 3)
Segmental extent of tr 15
Values are mean  SD orPCI without a history of prior MI and subsequent
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329Q waves. In our study, the incidence of pathological
Q waves was 58% 1 h after PCI, based on the 2007
criteria. The classic criteria were stricter, labeling
23% of the patients as having pathological Q waves.
Other studies have provided wide ranges of Q-wave
MI incidence, partly depending on which criteria
were used. A recent study found an incidence of
57% using 2007 criteria, which is comparable to this
study (4).
Q-wave and different criteria. The criteria for patho-
ogical Q waves have changed over the years. Jensen et
l. (17) already addressed the redefinition of the
-wave when comparing the classic criteria with the
onsensus document in 2000 to assess prior myocar-
ial infarction. They found in 79 patients with and 77
atients without previous MI that the 2000 criteria
ere nonspecific, resulting in a high number of false-
ositive results. However, they only compared 2 def-
nitions and used misquoted criteria from the 2000
onsensus document. Nowadays, 4 different sets of
riteria are used in daily clinical practice. To our
nowledge, our study is the first to compare these
ifferent Q-wave criteria. We found that of these 4
ifferent pathological Q-wave criteria, the distinction
ased on the classic criteria was the best predictor of
nfarct size on CMR. This is probably due to more
trict criteria compared with the new criteria, thus
esulting in a lower number of false positives.
Q-wave and prediction of LVEF and infarct size. In the
resent study, Q-wave MI was associated with larger
nfarct size and lower LVEF, both at baseline as well
s at follow-up. This confirms earlier studies showing
arger MIs as assessed with CMR in Q-wave MI
atients (2–4). However, to our knowledge, we are
P< 0.001
LV
EF
%
Baseline 4 Months
33%
36%
39%
42%
45%
48%
51%
Figure 2. Q-Wave Regression Compared With Persistent Q-Wave MI
Patients with Q-wave regression displayed signiﬁcantly larger left v
(9  11%) as compared with both Q-wave myocardial infarction (M
comparisons).he first to assess the Q-wave/non–Q-wave MI dis-inction in a large population using CMR up to 24
onths of follow-up, showing that the Q-wave dis-
inction remains clinically relevant.
Q-wave and regression. Though Q waves are con-
idered to be permanent stigmata of infarction,
everal large studies in the thrombolytic era have
hown they disappear in as much as 15% of all cases
11–13). The disappearance of Q waves has even
een documented after successful myocardial revas-
ularization by coronary artery bypass grafting (18).
n the era of primary PCI, there has been only 1
eport to date where Q-wave regression was as-
essed (19). Q-wave regression in2 leads occurred
n approximately 10% to 20% of the study popula-
ion. In that study, conducted by Iwasaki et al. (19),
he researchers did not find a correlation between
he incidence of Q-wave regression and LVEF, LV
olumes, or regional wall motion. This was, how-
ver, investigated in a small population of 94
atients, of which only 47 patients were treated
ith primary PCI.
C O N C L U S I O N S
In the present study, we show that Q-wave regression
is associated with LVEF improvement. Thus, for the
first time, we now show that there is indeed a direct
relationship between functional LV recovery after MI
and the disappearance of initial Q waves.
A new ventricular conduction disturbance may alter
activation pathways and mask prior Q waves. Simi-
larly, a second MI involving the contralateral ventric-
ular wall may cause an apparent regrowth of R waves
over the area of previous infarct. However, we ex-
P = 0.02
Non–Q-wave MI
Q-Wave Regression
Persistent Q-Wave MI
24 Months
Non–Q-Wave MI and LVEF Improvement During 24 Months
icular ejection fraction (LVEF) improvement in 24 months
 8%) and non–Q-wave MI (3  8%, p  0.04 for bothand
entr
I) (2cluded patients with a clinical evidence of re-
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Figure 3. Regional Wall Thickness and Function in Dysfunctional Segments
(A) Wall thickening in dysfunctional segments at baseline, 4 months, and 24 months stratiﬁed to Q-wave regression, persistent Q-wave myocardial infarction (MI),
and non–Q-wave MI. (B) Change in end-diastolic wall thickness (mm) stratiﬁed to Q-wave regression, persistent Q-wave MI, and non–Q-wave MI. (C) Change in
end-systolic wall thickness (mm) stratiﬁed to Q-wave regression, persistent Q-wave MI, and non–Q-wave MI. (D) Improvement in wall thickening (mm) stratiﬁed
to Q-wave regression, persistent Q-wave MI, and non–Q-wave MI.
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331infarction, and also the marked improvement of LV
function in this specific group of patients suggests
differently. We observed that the presence of MVO
was strongly related to persistence of Q waves. We
and others have previously shown the correlation
between MVO and LV functional recovery (20,21).
Apparently, MVO reflects, not only MVO, but also
severity of myocardial damage and a lower capacity to
regain function. True myocardial healing also cannot
be excluded, although the regenerative capacity of the
myocardium is known to be very limited. Neverthe-
less, Q-wave regression points out a separate group of
patients with a larger than average capability to recover
LV function after PCI treated acute MI.
Study limitations. The Minnesota criteria have alsotransmural myocardial infarction.
Am J Cardiol 1973;31:595–9.
1
1
1
1
1
1
cardial infarct size.
Img 2009;2:1187–9riteria are based on computer algorithms and
eveloped for epidemiological studies and clinical
rials. In our study, we did not use these criteria
ecause we focused on readily available definitions
hat can be used in daily clinical practice. Also, this
tudy is limited by a small sample size, especially in
he group with Q-wave regression. However, de-
pite the limited sample size, we have observed
tatistically significant and clinically relevant differ-
nces between patients without Q waves, persistent
waves, and Q-wave regression.
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